Optimizing adaptive design for Phase 2 dose-finding trials incorporating long-term success and financial considerations: A case study for neuropathic pain
2017
Abstract In this paper, we propose an adaptive randomization design for Phase 2 dose-finding trials to optimize
Net Present Value(NPV) for an
experimental drug. We replace the traditional fixed sample size design (Patel, et al., 2012) by this
new designto see if NPV from the original paper can be improved. Comparison of the proposed design to the previous design is made via simulations using a hypothetical example based on a Diabetic
Neuropathic PainStudy.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
7
References
0
Citations
NaN
KQI